BioLineRx Cash Flow Statement (2013-2025) | BLRX

Cash Flow Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-5.03M-6.02M-5.66M-6.39M-5.83M-7.08M-6.55M-7.07M-7.39M-7.60M-10.23M-19.50M-3.33M-2.59M-2.23M0.05M-1.68M-1.24M-0.74M-3.11M
Gains from Sales and Divestitures (Quarter)
0.03M
Gains from Investment Securities (Quarter)
4.60M0.29M-0.80M-2.15M-1.25M-0.42M-1.10M-3.65M3.04M7.80M3.12M-2.91M-4.44M-8.40M-0.72M-5.40M-8.31M1.90M-1.13M-1.05M
Non-cash Items (Quarter)
3.96M6.16M4.68M-0.66M0.50M-1.34M-1.29M4.15M13.68M19.13M38.01M-13.41M-25.23M-29.23M-34.65M-7.72M-5.31M-5.08M-6.05M
Cash from Operations (Quarter)
-6.23M-6.83M-5.01M-5.50M-5.59M-6.29M-8.68M-5.68M-8.02M-9.68M-9.90M4.99M-14.11M-11.33M-9.82M-8.61M-2.59M-0.18M-2.11M-3.20M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.03M0.70M
Amortization (Quarter)
5.44M-1.80M-0.83M-1.19M4.15M18.88M-13.41M20.01M-7.72M4.24M
Depreciation & Amortization (CF) (Quarter)
0.18M0.18M0.17M0.17M0.17M0.14M0.15M0.19M0.26M0.20M0.22M0.71M0.90M0.48M0.84M1.85M0.17M0.18M0.12M0.06M
Change in Working Capital
Change in Receivables (Quarter)
-2.47M-0.35M-0.43M1.14M1.01M1.39M0.08M-0.05M
Change in Inventory (Quarter)
-1.35M-0.60M-0.94M-0.74M0.09M0.40M-0.17M0.47M0.67M0.03M
Change in Account Payables (Quarter)
-0.50M-0.47M0.18M0.23M0.25M1.42M-1.29M1.50M0.39M-0.11M2.13M3.10M-3.51M-2.12M-0.59M0.71M
Change in Accured Expenses (Quarter)
-0.50M-0.47M0.18M-3.51M-2.12M-0.59M-2.51M0.03M-0.57M
Other Working Capital Changes (Quarter)
-0.98M-0.24M0.86M0.37M-0.08M-0.61M0.28M-0.24M-0.12M-0.84M0.39M13.52M-3.93M-3.55M-3.22M-2.25M1.16M-1.16M0.79M0.52M
Investing Activities
Capital Expenditures (Quarter)
-0.02M-0.02M0.00M-0.06M-0.02M-0.04M-0.01M-0.06M-0.03M-0.07M-0.00M-0.02M-0.03M-0.03M0.01M
Change in Intangibles (Quarter)
-0.01M-0.17M-0.10M-0.06M-0.03M-0.00M
Change in Acquisitions & Divestments (Quarter)
-42.00M-16.00M-12.00M-8.00M-7.00M-2.00M-27.00M-8.00M-5.50M-0.51M-7.88M-33.71M16.72M-37.28M-5.79M-12.31M-12.51M-4.21M-7.62M
Cash from Investing Activities (Quarter)
-36.26M-6.00M0.04M4.00M5.05M10.03M-14.94M3.86M6.64M11.10M4.10M-20.39M16.69M-8.64M10.18M11.16M-8.18M-3.70M3.67M-0.34M
Financing Activities
Cash from Financing Activities (Quarter)
41.91M14.09M1.57M0.17M-0.94M-0.69M22.72M-0.65M-0.05M-0.13M3.50M11.74M-0.89M23.88M-1.22M-1.11M9.45M1.60M-0.92M-1.25M
Additional items
Exchange Rate Effect (Quarter)
-0.20M0.23M-0.07M0.24M-0.06M0.62M-1.12M-0.05M-0.10M-0.25M-0.07M0.19M0.05M-0.27M0.08M0.16M-0.08M0.43M0.07M0.12M
Change in Cash (Quarter)
-0.58M1.26M-3.40M-1.33M-1.48M3.05M-0.90M-2.47M-1.42M1.28M-2.31M-3.66M1.68M3.90M-0.87M1.44M-1.32M-2.28M0.65M-4.79M
Beginning Cash Balance (Quarter)
-0.81M-0.83M-0.85M-0.90M-0.92M-1.02M-0.80M-0.74M-0.77M-0.78M-0.91M-11.97M-1.12M-1.12M-1.12M-1.14M
Free Cash Flow (Quarter)
-6.21M-6.81M-5.02M-5.44M-5.57M-6.25M-8.67M-5.63M-7.98M-9.62M-9.90M5.01M-14.08M-11.30M-9.82M-8.62M-2.59M-0.18M-2.11M-3.20M
Net Cash Flow (Quarter)
-0.58M1.26M-3.40M-1.33M-1.48M3.05M-0.90M-2.47M-1.42M1.28M-2.31M-3.66M1.68M3.90M-0.87M1.44M-1.32M-2.28M0.65M-4.79M